OK Biotech Co (TPE:4155) Interest Expense: NT$-11 Mil (TTM As of Dec. 2025)


TPE:4155 OK Biotech Co Ltd TPE:4155
65 GF Score
Price NT$15.60
GF Value NT$27.25
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is OK Biotech Co Interest Expense?

OK Biotech Co TPE:4155 65 Interest Expense is NT$-11 Mil as of Dec. 2025. GuruFocus rates TPE:4155 with a GF Score™ of 65/100 and a GF Value™ of NT$27.25 (Possible Value Trap). The stock has 8 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. OK Biotech Co's interest expense for the three months ended in Dec. 2025 was NT$ -4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-11 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. OK Biotech Co's Operating Income for the three months ended in Dec. 2025 was NT$ 20 Mil. OK Biotech Co's Interest Expense for the three months ended in Dec. 2025 was NT$ -4 Mil. OK Biotech Co's Interest Coverage for the quarter that ended in Dec. 2025 was 5.58. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

OK Biotech Co  (TPE:4155) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

OK Biotech Co's Interest Expense for the three months ended in Dec. 2025 was NT$-4 Mil. Its Operating Income for the three months ended in Dec. 2025 was NT$20 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2025 was NT$697 Mil.

OK Biotech Co's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2025 )/Interest Expense (Q: Dec. 2025 )
=-1*20.368/-3.65
=5.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

OK Biotech Co Interest Expense Historical Data

* Premium members only.

The historical data trend for OK Biotech Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OK Biotech Co Interest Expense Chart

OK Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.08 -11.42 -9.00 -6.23 -10.92

OK Biotech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.61 -2.28 -2.37 -2.62 -3.65
TPE:4155
65GF Score
OK Biotech Co Ltd TPE:4155
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OK Biotech Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of NT$-11 Mil mean?
OK Biotech Co (TPE:4155) has a Interest Expense of NT$-11 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on OK Biotech Co and its competitors.
Is OK Biotech Co's Interest Expense too high?
OK Biotech Co's current Interest Expense is NT$-11 Mil. Overall, OK Biotech Co has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OK Biotech Co's Interest Expense compare to ABT and SYK?
OK Biotech Co's Interest Expense of NT$-11 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on OK Biotech Co and its competitors. OK Biotech Co's current Interest Expense is NT$-11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OK Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, OK Biotech Co (TPE:4155) is currently considered Possible Value Trap. The stock's GF Value™ is NT$27.25, compared to a current price of NT$15.60 — trading 42.8% below its estimated fair value. The current Interest Expense is NT$-11 Mil. OK Biotech Co's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For OK Biotech Co (TPE:4155), the current Interest Expense is NT$-11 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OK Biotech Co (TPE:4155) Overvalued in 2026?

Based on GuruFocus' analysis, OK Biotech Co stock appears to be undervalued. The current stock price of NT$15.60 is trading 42.8% below its estimated GF Value™ of NT$27.25. GuruFocus considers OK Biotech Co to be Possible Value Trap.

Key valuation signals for TPE:4155:

  • Interest Expense: NT$-11 Mil
  • GF Value™: NT$27.25 vs. price of NT$15.60 (42.8% below fair value)
  • GF Score™: 65/100 with 8 warning signs

No single metric tells the full story. See the TPE:4155 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OK Biotech Co Business Description

Address Gongdao 5th Road, Section 2, No. 91, Hsinchu, TWN, 30070
OK Biotech Co Ltd is mainly engaged in the manufacturing, wholesale, and retail of electronic materials and medical equipment. Its product portfolio comprises blood glucose monitoring systems, OTC hearing aids, multi-frequency therapy devices, and others. Geographically, the company generates the majority of its revenue from America, and the rest from Asia (excluding Taiwan), Africa, Europe, and Taiwan.
65GF Score

Get the complete analysis for TPE:4155

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.60
Price
NT$27.25
GF Value